Mulholland,PERSON
and,O
Sinha,PERSON
BMC,O
Medicine,O
Open,O
Access,O
Ethnicity,O
and,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
:,O
are,O
the,O
pieces,O
of,O
the,O
puzzle,O
falling,O
into,O
place,O
?,O
Rachel,PERSON
H.,PERSON
Mulholland1,PERSON
and,O
Ian,PERSON
P.,PERSON
Sinha2,PERSON
.3,NUMBER
*,O
Keywords,O
:,O
COVID,O
‐,O
19,NUMBER
.,O
Ethnic,MISC
inequalities,O
.,O
UK,COUNTRY
Biobank,ORGANIZATION
.,O
Public,O
health,O
.,O
Epi,PERSON
‐,PERSON
demiology,O
The,O
COVID,O
‐,O
19,NUMBER
pandemic,O
is,O
exposing,O
problems,O
within,O
our,O
societies,O
.,O
and,O
as,O
always,O
.,O
vulnerable,O
groups,O
are,O
hit,O
hardest,O
.,O
One,NUMBER
key,O
story,O
around,O
COVID,O
‐,O
19,NUMBER
.,O
particularly,O
in,O
the,O
UK,COUNTRY
and,O
USA,COUNTRY
.,O
has,O
been,O
inequality,O
in,O
COVID,O
‐,O
19,NUMBER
outcomes,O
between,O
people,O
from,O
differ,O
‐,O
ent,O
ethnic,O
backgrounds,O
.,O
Reports,O
of,O
such,O
differences,O
initially,O
emerged,O
from,O
certain,O
states,O
in,O
the,O
USA,COUNTRY
.,O
where,O
rates,O
of,O
hospitali,O
‐,O
sation,O
and,O
death,O
from,O
COVID,O
‐,O
19,NUMBER
were,O
higher,O
in,O
Black,O
people,O
than,O
would,O
be,O
expected,O
from,O
the,O
ethnic,O
composition,O
of,O
the,O
population,O
[,O
1,NUMBER
],O
.,O
Similar,O
findings,O
are,O
shown,O
in,O
the,O
UK,COUNTRY
.,O
where,O
Black,O
and,O
South,O
Asian,NATIONALITY
people,O
have,O
disproportionately,O
high,O
rates,O
in,O
intensive,O
care,O
[,O
2,NUMBER
],O
.,O
mortality,O
amongst,O
healthcare,O
workers,O
[,O
3,NUMBER
],O
and,O
the,O
general,TITLE
population,O
[,O
4,NUMBER
],O
.,O
and,O
the,O
development,O
of,O
paediatric,O
inflammatory,O
multisystem,O
syndrome,O
(,O
a,O
paediatric,O
hyperinflammatory,O
state,O
relat,O
‐,O
ed,O
to,O
COVID,O
‐,O
19,NUMBER
),O
[,O
5,NUMBER
],O
.,O
The,O
question,O
is,O
.,O
why,O
?,O
Linking,O
data,O
between,O
UK,COUNTRY
Biobank,ORGANIZATION
and,ORGANIZATION
Public,ORGANIZATION
Health,ORGANIZATION
England,ORGANIZATION
The,O
linked,O
paper,O
by,O
Niedzwiedz,O
et,O
al.,O
[,O
6,NUMBER
],O
adds,O
muchneeded,O
new,O
information,O
.,O
This,O
study,O
links,O
participants,O
in,O
the,O
UK,COUNTRY
Biobank,O
to,O
COVID,O
‐,O
19,NUMBER
testing,O
data,O
from,O
Public,LOCATION
Health,LOCATION
England,COUNTRY
(,O
PHE,O
),O
.,O
The,O
study,O
recruited,O
4070,NUMBER
‐,O
yearolds,O
and,O
recorded,O
their,O
baseline,O
characteristics,O
between,O
2006,DATE
and,O
2010,DATE
[,O
7,NUMBER
],O
.,O
Associations,O
between,O
the,O
baseline,O
data,O
.,O
in,O
particular,O
.,O
self,O
‐,O
reported,O
ethnicity,O
and,O
socioeconomic,O
Alder,O
Hey,O
Childrens,ORGANIZATION
Hospital,ORGANIZATION
.,O
Liverpool,CITY
.,O
UK,COUNTRY
status,O
(,O
deprivation,O
and,O
highest,O
education,O
),O
.,O
were,O
explored,O
and,O
compared,O
in,O
COVID,O
‐,O
19,NUMBER
testing,O
.,O
test,O
‐,O
ing,O
positive,O
and,O
testing,O
positive,O
in,O
a,O
hospital,O
setting,O
.,O
Results,O
were,O
adjusted,O
for,O
potential,O
confounding,O
and,O
mediating,O
factors,O
that,O
reflected,O
the,O
health,O
and,O
social,O
status,O
of,O
the,O
participants,O
.,O
Of,O
392.116,NUMBER
participants,O
in,O
the,O
cohort,O
.,O
2658,DATE
were,O
tested,O
for,O
COVID,O
‐,O
19,NUMBER
.,O
of,O
whom,O
948,NUMBER
tested,O
positive,O
.,O
Compared,O
to,O
the,O
White,O
British,NATIONALITY
population,O
.,O
positive,O
tests,O
were,O
more,O
likely,O
in,O
Black,O
(,O
relative,O
risk,O
(,O
RR,O
),O
3.35,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
2.48,NUMBER
4.53,NUMBER
),O
),O
.,O
South,MISC
Asian,NATIONALITY
(,O
RR,O
2.42,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
1.753.36,NUMBER
),O
and,O
White,O
Irish,NATIONALITY
(,O
RR,O
1.42,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
1.002.03,NUMBER
),O
),O
people,O
.,O
When,O
breaking,O
down,O
into,O
more,O
detailed,O
cate,O
‐,O
gories,O
.,O
Black,ORGANIZATION
Caribbean,ORGANIZATION
(,O
RR,O
3.51,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
2.395.15,NUMBER
),O
and,O
Pakistani,NATIONALITY
(,O
RR,O
3.24,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
1.736.07,NUMBER
),O
),O
ethnic,O
groups,O
had,O
respectively,O
the,O
highest,O
risk,O
ratio,O
in,O
the,O
Black,O
and,O
South,MISC
Asian,NATIONALITY
ethnic,O
back,O
‐,O
grounds,O
.,O
The,O
risk,O
of,O
a,O
positive,O
test,O
was,O
also,O
linked,O
to,O
socioeco,O
‐,O
nomic,O
status,O
and,O
education,O
.,O
where,O
those,O
living,O
in,O
the,O
most,O
disad,O
‐,O
vantaged,O
quartile,O
(,O
RR,O
2.19,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
1.802.66,NUMBER
),O
),O
and,O
those,O
with,O
low,O
‐,O
er,O
levels,O
of,O
education,O
(,O
RR,O
2.00,NUMBER
(,O
95,PERCENT
%,PERCENT
CI,O
1.662.42,NUMBER
),O
),O
having,O
the,O
highest,O
risk,O
of,O
confirmed,O
COVID,O
‐,O
19,NUMBER
infection,CAUSE_OF_DEATH
.,O
Adjusting,O
for,O
po,O
‐,O
tential,O
risk,O
factors,O
.,O
including,O
country,O
of,O
birth,O
.,O
whether,O
they,O
are,O
a,O
healthcare,O
worker,O
.,O
socioeconomic,O
status,O
and,O
pre,O
‐,O
existing,O
health,O
.,O
did,O
not,O
fully,O
explain,O
these,O
ethnic,O
differences,O
.,O
Socioeco,O
‐,O
nomic,O
differences,O
.,O
however,O
.,O
appeared,O
to,O
make,O
the,O
most,O
substantial,O
contribution,O
to,O
these,O
ethnic,O
variations,O
.,O
Collaborations,O
such,O
as,O
these,O
are,O
needed,O
to,O
address,O
Biobank,O
UK,COUNTRY
and,O
PHE,O
),O
should,O
be,O
com,O
‐,O
mended,O
for,O
enabling,O
and,O
conducting,O
a,O
linked,O
data,O
study,O
of,O
this,O
scale,O
so,O
quickly,O
.,O
Insights,O
are,O
extremely,O
useful,O
and,O
further,O
evi,O
‐,O
dence,O
of,O
what,O
has,O
been,O
previously,DATE
seen,O
in,O
ethnic,O
groups,O
which,O
permits,O
use,O
.,O
sharing,O
.,O
adaptation,O
.,O
distribution,O
and,O
reproduction,O
in,O
any,O
medium,O
or,O
format,O
.,O
as,O
long,O
as,O
you,O
give,O
licence,O
and,O
your,O
in,O
‐,O
tended,O
use,O
is,O
not,O
permitted,O
by,O
statutory,O
regulation,O
or,O
exceeds,O
the,O
permitted,O
use,O
.,O
you,O
will,O
need,O
to,O
obtain,O
Mulholland,PERSON
and,O
Sinha,PERSON
BMC,ORGANIZATION
Medicine,ORGANIZATION
and,O
socioeconomic,O
backgrounds,O
in,O
relation,O
to,O
COVID19,O
.,O
Nonetheless,O
.,O
there,O
are,O
potential,O
limitations,O
to,O
cohort,O
studies,O
using,O
UK,COUNTRY
Biobank,O
.,O
Firstly,O
.,O
the,O
cohort,O
consists,O
of,O
volun,O
‐,O
teers,O
meaning,O
results,O
may,O
not,O
reflect,O
the,O
whole,O
UK,COUNTRY
with,O
complete,O
accuracy,O
.,O
In,O
particular,O
.,O
this,O
study,O
only,O
uses,O
participants,O
from,O
English,NATIONALITY
assessment,O
centres,O
who,O
were,O
aged,O
4070,DURATION
years,DURATION
when,O
recruit,O
‐,O
ed,O
and,O
therefore,O
can,O
not,O
be,O
generalised,O
nationally,O
.,O
Secondly,O
.,O
the,O
baseline,O
characteristics,O
of,O
participants,O
were,O
recorded,O
over,O
10,NUMBER
years,DATE
ago,DATE
and,O
may,O
have,O
changed,O
since,O
they,O
were,O
enrolled,O
.,O
In,O
addi,O
‐,O
tion,O
.,O
the,O
models,O
only,O
adjust,O
for,O
risk,O
factors,O
and,O
do,O
not,O
explore,O
potential,O
interactions,O
between,O
the,O
exposures,O
and,O
risk,O
factors,O
.,O
Investigating,O
these,O
may,O
add,O
extra,O
value,O
to,O
insights,O
to,O
evaluate,O
whether,O
ethnic,O
differences,O
occur,O
differently,O
in,O
the,O
potential,O
confounding,O
factors,O
.,O
Alongside,O
this,O
analysis,O
.,O
further,O
data,O
from,O
people,O
in,O
hospitals,O
and,O
care,O
homes,O
would,O
help,O
identify,O
where,O
along,O
the,O
patient,O
pathways,O
the,O
problems,O
lie,O
.,O
Where,O
next,O
?,O
In,O
or,O
‐,O
der,O
for,O
population,O
‐,O
level,O
interventions,O
and,O
policies,O
to,O
be,O
impact,O
‐,O
ful,O
.,O
we,O
urgently,O
need,O
to,O
develop,O
a,O
mechanistic,O
understanding,O
of,O
the,O
increased,O
risk,O
to,O
different,O
communities,O
.,O
A,O
holistic,O
approach,O
should,O
be,O
adopted,O
.,O
alongside,O
more,O
detailed,O
and,O
up,O
‐,NUMBER
to,O
‐,O
date,O
infor,O
‐,O
mation,O
around,O
social,O
issues,O
that,O
differ,O
between,O
ethnic,O
groups,O
.,O
such,O
as,O
environmental,O
conditions,O
(,O
including,O
overcrowding,O
.,O
inter,O
‐,O
generational,O
living,O
.,O
standards,O
of,O
accommodation,O
and,O
exposure,O
to,O
pollution,O
),O
.,O
income,O
.,O
type,O
of,O
employment,O
and,O
working,O
conditions,O
.,O
Linking,O
data,O
with,O
health,O
records,O
would,O
enable,O
a,O
more,O
accurate,O
ex,O
‐,O
ploration,O
of,O
the,O
role,O
of,O
relevant,O
comorbiditiesnot,O
just,O
in,O
terms,O
of,O
prevalence,O
and,O
disease,CAUSE_OF_DEATH
control,O
but,O
also,O
the,O
quality,O
of,O
care,O
.,O
Public,O
health,O
messaging,O
to,O
different,O
ethnic,O
groups,O
requires,O
exam,O
‐,O
ination,O
.,O
to,O
ensure,O
it,O
is,O
clear,O
and,O
culturally,O
appropriate,O
at,O
the,O
local,O
and,O
governmental,O
levels,O
.,O
There,O
is,O
interest,O
in,O
genetic,O
and,O
biological,O
reasons,O
that,O
explain,O
these,O
ethnic,O
inequalities,O
.,O
but,O
to,O
date,O
.,O
this,O
is,O
only,O
speculative,O
.,O
Theories,O
around,O
the,O
expression,O
of,O
human,O
leukocyte,O
antigen,O
haplotypes,O
.,O
angiotensin,O
‐,O
converting,O
enzyme,O
receptors,O
and,O
vitamin,O
D,O
levels,O
in,O
dark,O
‐,O
skinned,O
people,O
have,O
not,O
been,O
validated,O
.,O
The,O
role,O
of,O
these,O
factors,O
in,O
COVID,O
‐,O
19,NUMBER
disease,CAUSE_OF_DEATH
is,O
poorly,O
understood,O
.,O
and,O
no,O
group,O
has,O
yet,O
linked,O
them,O
with,O
ethnici,O
‐,O
ty,O
and,O
COVID,O
‐,O
19,NUMBER
outcome,O
in,O
a,O
meaningful,O
way,O
to,O
explain,O
the,O
stark,O
inequalities,O
[,O
810,NUMBER
],O
.,O
Research,O
on,O
ethnic,O
inequalities,O
from,O
COVID,O
‐,O
19,NUMBER
is,O
still,O
lacking,O
.,O
and,O
most,O
countries,O
with,O
high,O
levels,O
of,O
infection,CAUSE_OF_DEATH
have,O
not,O
yet,O
released,O
data,O
around,O
this,O
issue,O
.,O
Further,O
qualitative,O
and,O
quantitative,O
research,O
.,O
grounded,O
in,O
public,O
health,O
and,O
social,O
sciences,O
.,O
is,O
urgently,O
needed,O
.,O
Resources,O
like,O
the,O
UK,COUNTRY
Biobank,ORGANIZATION
will,O
enable,O
both,O
epidemiological,O
and,O
biological,O
research,O
.,O
and,O
the,O
linked,O
study,O
is,O
an,O
example,O
of,O
how,O
useful,O
studies,O
can,O
be,O
done,O
rapidly,O
.,O
The,O
ethnic,O
inequalities,O
in,O
COVID,O
‐,O
19,NUMBER
are,O
of,O
grave,O
importance,O
.,O
The,O
response,O
needs,O
to,O
be,O
collaborative,O
.,O
meaningful,O
.,O
transparent,O
.,O
sensitive,O
.,O
holistic,O
and,O
swift,O
.,O
COVID,O
‐,O
19,NUMBER
:,O
Coron,O
‐,O
avirus,O
disease,CAUSE_OF_DEATH
2019,DATE
;,O
PHE,O
:,O
Public,LOCATION
Health,LOCATION
England,COUNTRY
;,O
RR,O
:,O
Relative,O
Not,O
applicable,O
No,O
external,O
sources,O
of,O
funding,O
Availability,O
of,O
data,O
and,O
materials,O
Not,O
applicable,O
Ethics,MISC
approval,O
and,O
consent,O
to,O
par,O
‐,O
ticipate,O
Not,O
applicable,O
Consent,O
for,O
publication,O
Not,O
applicable,O
Competing,O
interests,O
1,NUMBER
.,O
Garg,PERSON
S,O
.,O
Kim,PERSON
L,PERSON
.,O
Whitaker,PERSON
M,O
.,O
et,O
al,O
.,O
Hospi,O
‐,O
talization,O
rates,O
and,O
characteristics,O
of,O
patients,O
hospitalized,O
with,O
laboratory,O
‐,O
confirmed,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019COVID,O
‐,O
NET,O
.,O
14,NUMBER
States,O
.,O
March,DATE
130,NUMBER
.,O
MMWR,ORGANIZATION
Morb,ORGANIZATION
Mortal,ORGANIZATION
Wkly,ORGANIZATION
Rep.,TITLE
2,NUMBER
.,O
Intensive,O
Care,O
National,ORGANIZATION
Audit,ORGANIZATION
and,ORGANIZATION
Research,ORGANIZATION
Centre,ORGANIZATION
(,O
ICNARC,O
),O
.,O
ICNARC,ORGANIZATION
report,O
3,NUMBER
.,O
M.,O
Weaver,TITLE
.,O
A.,PERSON
Mohdin,PERSON
.,O
H.,PERSON
Pidd,PERSON
.,O
et,O
al,O
.,O
So,O
much,O
living,O
to,O
do,O
:,O
stories,O
of,O
UKs,O
4,NUMBER
.,O
The,O
Office,ORGANIZATION
for,ORGANIZATION
National,ORGANIZATION
Statistics,ORGANIZATION
(,O
ONS,ORGANIZATION
),O
.,O
Coronavirus,O
(,O
COVID,O
‐,O
19,NUMBER
),O
related,O
deaths,O
by,O
ethnic,O
group,O
.,O
England,COUNTRY
and,O
Wales,LOCATION
:,O
2,NUMBER
March,DATE
2020,DATE
to,O
10,DATE
April,DATE
2020,DATE
.,O
5,NUMBER
.,O
Riphagen,PERSON
S,PERSON
.,O
Gomez,PERSON
X,PERSON
.,O
Gonzalez,PERSON
‐,O
Martinez,PERSON
C,O
.,O
et,O
al,O
.,O
Hyperinflammatory,O
shock,O
6,NUMBER
.,O
Niedzwiedz,ORGANIZATION
CL,ORGANIZATION
.,O
ODonnell,PERSON
CA,STATE_OR_PROVINCE
.,O
Jani,PERSON
BD,PERSON
.,O
et,O
al,O
.,O
Ethnic,O
and,O
socioeconomic,O
differences,O
in,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
infection,CAUSE_OF_DEATH
:,O
prospective,O
cohort,O
study,O
using,O
UK,COUNTRY
8,NUMBER
.,O
Hastie,PERSON
CE,O
.,O
MacKay,O
DF,O
.,O
Ho,O
F,O
.,O
et,O
al,O
.,O
Vitamin,O
D,O
concentrations,O
and,O
COVID,O
‐,O
19,NUMBER
Mulholland,PERSON
and,O
Sinha,ORGANIZATION
BMC,ORGANIZATION
Medicine,ORGANIZATION
Li,ORGANIZATION
Q,O
.,O
Cao,PERSON
Z,PERSON
.,O
Rahman,PERSON
P,O
.,O
et,O
al,O
.,O
Genetic,O
variability,O
of,O
human,O
angiotensinconverting,O
enzyme,O
2,NUMBER
(,O
hACE2,O
),O
among,O
various,O
ethnic,O
populations,O
.,O
bioRxiv,O
.,O
10,NUMBER
.,O
Nguyen,PERSON
A,O
.,O
David,PERSON
JK,PERSON
.,O
Maden,PERSON
SK,STATE_OR_PROVINCE
.,O
et,O
al,O
.,O
Human,O
leukocyte,O
antigen,O
